🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT07255001
Recruiting Not applicable

Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life

NCT07255001 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2026-08-13
Last updated
2026-09-15

Condition(s) studied

Pancreatic Ductal Adenocarcinoma (PDAC)Hand Grip Strength

Investigational drug(s) / intervention(s)

Hand grip strength assessments using a dynamometer

Hand grip strength assessments using a dynamometer: Squeeze a dynamometer with one hand to measure hand grip strength.

Study summary

The goal of this clinical trial is to measure hand grip strength in adults with pancreatic ductal adenocarcinoma (PDAC). The main questions it aims to answer are:

* Is it feasible to measure hand grip strength as part of a clinic visit?
* Are changes in hand grip strength related to changes in body composition?
* Is hand grip strength related to a person's well-being?
* Is hand grip strength related to how a tumour responds to treatment?

Participants will squeeze a device with their hand to measure their hand grip strength and complete questionnaires about their well-being when they are seen in clinic for their regular medical care for PDAC.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 18 years or older. * Histological and/or radiological diagnosis of resectable, non-resectable, or metastatic PDAC. For resectable PDAC, adjuvant setting only. * ECOG performance status 0-2. * Life expectancy greater than 6 months as judged by the investigator. * Planned for treatment, either as part of routine care or in combination with an investigational agent within another study. * Ability to hold a dynamometer with one hand. Exclusion Criteria: * Individuals with CT imaging performed outside of Vancouver, BC, Canada. * Individuals who are unfit to undergo CT imaging of the third lumbar vertebra (L3). * Individuals who are currently participating in a structured moderate intensity resistance training program. * Individuals who are otherwise judged by the investigator to be unfit to proceed with this protocol. * Unable to comply with study assessments and follow-up.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
BC Cancer Vancouver British Columbia Recruiting

More British Columbia Cancer Agency trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07255001 on ClinicalTrials.gov ↗ ← All trials in Canada